Amplify to start at the end of the month. I'd expect we hear from AT via ASX announcement on Monday???
ttppxx - would love to hear your thoughts on the study plan/design (especially given your knowledge of the COBRA trial protocol).
My initial thoughts:
- Inclusion criteria: participant potentially eligible for salvage radiotherapy with curative intent. Improved outcomes anyone...now why on earth would CU6 be trying to demonstrate improved outcomes... - Inclusion criteria: participant willing to undergo biopsy of SARbisPSMA positive lesion. I note that this wasn't an inclusion criteria of COBRA - ttppxx, would love your thoughts on this given your knowledge of the COBRA trial protocol and the issue surrounding biopsies...
CU6 Price at posting:
$2.50 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
